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We have previously found an increased risk of breast cancer among women born preterm. To confirm or refute the results, an
enlarged study was conducted. The results from this study do not confirm the initial findings and suggest that preterm birth can be
ruled out as a risk factor for breast cancer.
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Oestrogens are fundamental hormones in breast cancer aetiology,
and it has been suggested that the surge in oestrogens during
pregnancy may influence subsequent breast cancer risk in the
offspring (Trichopoulos, 1990).
Infants born extremely preterm, that is before 28 weeks of
gestation, has been found to have high levels of oestrogens
postnatally (Sedin et al, 1985). In a study of women born
between 1925 and1932, we found that birth before 32 weeks
of gestation constituted a strong risk factor for adult breast
cancer (Ekbom et al, 2000). The study, however, was hampered
by low statistical power. We therefore conducted an enlarged
study of the association between preterm birth and female
breast cancer.
MATERIALS AND METHODS
We identified the study subjects by examining manually all
birth records for the period 1925–1949 from Uppsala
University Hospital, Sundsvalls County Hospital, and two major
delivery units in Stockholm (Allma ¨nna BB and So ¨dra BB).
Approximately 250000 birth records were examined. Female
subjects born before 35 completed weeks of gestation according
to date of last menstrual period, and females born after 35 weeks
with a birth weight of less than 2000g were included. At the point
of initial inclusion into the cohort, data on pregnancy and
delivery, such as date of last menstrual period and birth weight,
was recorded.
By use of the National Registration Number, the cohort
was followed up in the Swedish Register of Population and
Population Changes from 1 January 1958 to 31 December 1998 or
to death or emigration prior to this time. Subjects who deceased
before 1958 were excluded, since incident cancers could not
be identified with any completeness prior to the initiation
of the Swedish Cancer Register. We identified cases of cancer
by linking our subjects to the Swedish Cancer Register. The
completeness of this register is over 98% (Mattsson and Wallgren,
1984).
We used last menstrual period to estimate gestational duration.
We categorised gestational duration into three groups: 32
completed weeks or less, 33–34 weeks, and 35 weeks or more.
Birth weight was categorised into less than 2000g, 2000–2999g,
and 3000g or more. Since an unreasonably high birth weight for a
short duration of gestation indicated an underestimation of
gestational duration or an overestimation of birth weight, we
excluded subjects born before 32 weeks of gestation with a birth
weight of 3000g or more (n¼155), and subjects with a gestational
duration of 33–34 weeks with a birth weight of 3600g or more
(n¼94).
We calculated standardised incidence ratios (SIR) for all female
cancer, female breast cancer, and early onset female breast cancer
using age, sex, and time-specific cancer incidence rates for the
Swedish population during the period 1958–1998 provided by the
Cancer Registry. We analysed all cancer occurrences as well as the
first cancer occurrence. As these estimates were essentially the
same, we only present the results from the analysis of first cancer
occurrence.
RESULTS
There were 1483 women who met the eligibility criteria and
of these, 1208 were born before 35 weeks of gestation and 275
were born after week 35 with a birth weight of less than 2000g
(Table 1).
The overall risk of cancer among the women was not increased
(Table 2). The risk of breast cancer was neither associated with
preterm birth nor with low birth weight, but a birth weight of more
than 3000g was associated with an increased risk of breast cancer
(Table 2). This increase in breast cancer risk was not dependent on
age at onset.
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This study is, to our knowledge, the largest cohort study hitherto
conducted on long-term cancer risk among women born preterm
or with low birth weight. Neither preterm birth nor low birth
weight were associated with an increased risk for cancer overall or
for breast cancer.
We have previously reported an increased risk for breast cancer
among women born before 32 weeks of gestation( Ekbom et al,
1997; Ekbom et al, 2000). Other studies of the association between
gestational duration and breast cancer have been mostly negative
(Le Marchand et al, 1988; Michels et al, 1996; Sanderson et al,
1996; Sanderson et al, 1998), but these studies have categorised
preterm birth either as a dichotomous variable(Le Marchand et al,
1988; Sanderson et al, 1996; Sanderson et al, 1998), or as preterm
birth of more or less than 4 weeks(Michels et al, 1996). Since the
majority of preterm infants are born after 32 weeks of gestation,
the number of infants born before 32 weeks has been low. In a
recent case–control study, however, a reduced risk for breast
cancer was found among women born before 32 weeks (Innes et al,
2000), and as suggested by the present data, our previous results
were either due to chance, or confined to a subset of women with
specific characteristics.
Consistent with other studies (Potischman and Troisi, 1999;
Innes et al, 2000; Stavola et al, 2000), we found a positive
association between birth weight and breast cancer risk, and this
association was independent of age at diagnosis. Some studies have
reported the association between birth weight and breast cancer to
be J-shaped, with an increased risk also among women with a very
low birth weight (Potischman and Troisi, 1999; Innes et al, 2000).
According to the present data, low birth weight is not a major risk
factor for breast cancer.
When Trichopoulos (1990) put forward his hypothesis of early
environmental exposures, the proposed mechanism was oestrogen
exposure. Since then, a vast number of studies have supported his
hypothesis, although hormones other than oestrogen may be
instrumental (Potischman and Troisi, 1999). Our primary study of
preterm women was originally initiated because of reports of an
ovarian hyper stimulation syndrome among female infants born
before 28 weeks of gestation, which lead to high levels of
oestrogens perinatally (Tapanainen et al, 1981; Sedin et al, 1985).
The increase in breast cancer risk was interpreted as indicating an
important role of early oestrogen exposure (Ekbom et al, 2000).
We conclude from the present study that there is no substantial
increase in breast cancer risk among women born preterm. We
cannot, however, draw conclusions about the role of hormones or
ovarian hyper stimulation syndrome on basis of our data.
The use of self-reported date of last menstrual period leads to
some misclassification in the calculation of gestational duration.
The nature of this misclassification is both nondifferential and
Table 1 Study subjects by category, gestational duration, and birth
weight
Study subjects No. Percentage (%)
All 1483 100
Small-for-gestational-age
a 275 18.5
Preterm
All 1208 81.5
p32weeks 514 34.7
33–34weeks 694 46.8
Birth weight
0.5–1.99kg 703 47.4
2–2.99kg 691 46.6
X3kg 89 6.0
Gestational duration by birth weight
p32weeks
0.5–1.99kg 292 19.7
2–2.99kg 222 15.0
33–34weeks
0.5–1.99kg 136 9.2
2–2.99kg 469 31.6
X3kg 89 6.0
aBirth weighto2000g and gestational duration435 weeks.
Table 2 Standardised incidence ratios (SIR) and 95% confidence intervals (95% CI) for all female cancer, female breast cancer and female early onset
breast cancer
a by category, gestational duration, and birth weight
All cancers All breast cancer Early oneset breast cancer
a
Obs Exp SIR 95% CI Obs Exp SIR 95% CI Obs Exp SIR 95% CI
Small-for-gestational-age
b 20 26.7 0.75 0.46–1.16 10 9.2 1.09 0.52–2.01 4 3.8 1.06 0.29–2.71
Preterm
All 127 112.2 1.13 0.94–1.35 39 39.4 0.99 0.70–1.35 19 16.8 1.13 0.68–1.77
p32weeks 55 47.8 1.15 0.87–1.50 18 16.7 1.08 0.64–1.70 10 7.1 1.40 0.67–2.57
33–34weeks 72 64.4 1.12 0.88–1.41 21 22.7 0.92 0.57–1.41 9 9.7 0.93 0.43–1.77
Birth weight
c
0.5–1.99kg 45 39.9 1.13 0.82–1.51 16 14.0 1.14 0.65–1.85 9 5.9 1.53 0.70–2.91
2–2.99kg 63 64.7 0.97 0.75–1.25 16 22.7 0.71 0.40–1.15 7 9.7 0.72 0.29–1.49
X3kg 19 7.6 2.51 1.51–3.91 7 2.7 2.55 1.03–5.25 3 1.2 2.46 0.51–7.19
Gestational duration by birth weight
p32weeks
0.5–1.99kg 32 26.9 1.19 0.81–1.68 13 9.4 1.38 0.73–2.36 8 4.0 1.99 0.86–3.92
2–2.99kg 23 20.9 1.10 0.70–1.65 5 7.3 0.69 0.22–1.60 2 3.1 0.64 0.08–2.31
33–34weeks
0.5–1.99kg 13 13.1 1.00 0.53–1.70 3 4.6 0.65 0.13–1.91 1 1.8 0.54 0.01–3.01
2–2.99kg 40 43.7 0.91 0.65–1.25 11 15.4 0.72 0.36–1.28 5 6.6 0.76 0.25–1.77
X3kg 19 7.6 2.51 1.51–3.91 7 2.7 2.55 1.03–5.25 3 1.2 2.46 0.51–7.19
aOnset before 50 years of age.
bBirth weighto2000g and gestational duration435 weeks.
cAmong women born before 35 weeks of gestation.
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duration(Henriksen et al, 1995; Savitz et al, 2002). By exclusion of
subjects whose birth weights indicated an underestimation of
gestational duration, however, misclassification was reduced, and a
systematic overestimation of gestational duration can only lead to
a more conservative inclusion of subjects in the cohort. The main
limitation of the study is that study subjects were born between
1925 and 1949, but the follow-up did not start until 1958. The
cohort will therefore consist of women born more than 50 years
ago who survived beyond childhood. Given the increasing
proportion of survivors among infants born preterm or small-
for-gestational-age, other disease patterns may occur among
infants born preterm or small-for-gestational-age today.
In conclusion, we found that neither preterm birth, nor low
birth weight, are associated with an increased risk for breast
cancer.
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